Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature

References

• Arai, T., Ikeda, K., Akiyama, H., Nonaka, T., Hasegawa, M., Ishiguro, K., Iritani, S., Tsuchiya, K., Iseki, E., Yagishita, S., Oda, T., & Mochizuki, A. (2004). Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Annals of Neurology, 55(1), 72–79. https://doi.org/10.1002/ana.10793
   PubMed Web of Science ®Google Scholar
• Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., Josephs, K. A., Kertesz, A., Lee, S. E., Miller, B. L., Reich, S. G., Riley, D. E., Tolosa, E., Tröster, A. I., Vidailhet, M., & Weiner, W. J. (2013). Criteria for the diagnosis of corticobasal degeneration. Neurology, 80(5), 496–503. https://doi.org/10.1212/WNL.0b013e31827f0fd1
   Google Scholar
• Bak, T. H., & Hodges, J. R. (2008). Corticobasal degeneration: Clinical aspects. Handbook of Clinical Neurology, 89, 509–521. https://doi.org/doi:10.1016/S0072-9752(07)01247-X
   PubMedGoogle Scholar
• Barbier, P., Zejneli, O., Martinho, M., Lasorsa, A., Belle, V., Smet-Nocca, C., Tsvetkov, P. O., Devred, F., & Landrieu, I. (2019). Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects. Frontiers in Aging Neuroscience, 11. https://doi.org/10.3389/fnagi.2019.00204
   Google Scholar
• Boeve, B. F., Maraganore, D. M., Parisi, J. E., Ahlskog, J. E., Graff-Radford, N., Caselli, R. J., Dickson, D. W., Kokmen, E., & Petersen, R. C. (1999). Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology, 53(4), 795–800. https://doi.org/10.1212/wnl.53.4.795
   Google Scholar
• Buée, L., & Delacourte, A. (1999). Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and pick’s disease. Brain Pathology (Zurich, Switzerland), 9(4), 681–693. https://doi.org/doi:10.1111/j.1750-3639.1999.tb00550.x
   Google Scholar
• Chaste, P., Klei, L., Sanders, S. J., Hus, V., Murtha, M. T., Lowe, J. K., Willsey, A. J., Moreno-De-Luca, D., Yu, T. W., Fombonne, E., Geschwind, D., Grice, D. E., Ledbetter, D. H., Mane, S. M., Martin, D. M., Morrow, E. M., Walsh, C. A., Sutcliffe, J. S., Martin, C. L., … Devlin, B. (2015). A genomewide association study of autism using the Simons Simplex Collection: Does reducing phenotypic heterogeneity in autism increase genetic homogeneity? Biological Psychiatry, 77(9), 775–784. https://doi.org/10.1016/j.biopsych.2014.09.017
   Google Scholar
• Chen, J. A., Chen, Z., Won, H., Huang, A. Y., Lowe, J. K., Wojta, K., Yokoyama, J. S., Bensimon, G., Leigh, P. N., Payan, C., Shatunov, A., Jones, A. R., Lewis, C. M., Deloukas, P., Amouyel, P., Tzourio, C., Dartigues, J.-F., Ludolph, A., Boxer, A. L., … Coppola, G. (2018). Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. Molecular Neurodegeneration, 13(1), 41. https://doi.org/10.1186/s13024-018-0270–8
   Google Scholar
• D’souza, J., & Megginson, W. L. (1999). the financial and operating performance of privatized firms during the 1990s. The Journal of Finance, 54(4), 1397–1438. https://doi.org/doi:10.1111/0022-1082.00150
   Web of Science ®Google Scholar
• Di Maria, E., Tabaton, M., Vigo, T., Abbruzzese, G., Bellone, E., Donati, C., Frasson, E., Marchese, R., Montagna, P., Munoz, D. G., Pramstaller, P. P., Zanusso, G., Ajmar, F., & Mandich, P. (2000). Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Annals of Neurology, 47(3), 374–377. https://doi.org/10.1002/1531-8249(200003)47:3<374::aid-ana15>3.3.co;2–#
   Google Scholar
• Dickson, D. W., Bergeron, C., Chin, S. S., Duyckaerts, C., Horoupian, D., Ikeda, K., Jellinger, K., Lantos, P. L., Lippa, C. F., Mirra, S. S., Tabaton, M., Vonsattel, J. P., Wakabayashi, K., Litvan, I., & Office of Rare Diseases of the National Institutes of Health. (2002). Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. Journal of Neuropathology and Experimental Neurology, 61(11), 935–946. https://doi.org/10.1093/jnen/61.11.935
   Google Scholar
• Galvez-Contreras, A. Y., Campos-Ordonez, T., Gonzalez-Castaneda, R. E., & Gonzalez-Perez, O. (2017). Alterations of growth factors in autism and attention-deficit/hyperactivity disorder. Frontiers In Psychiatry / Frontiers Research Foundation, 8. https://doi.org/doi:10.3389/fpsyt.2017.00126
   Google Scholar
• Geier, E. G., Bourdenx, M., Storm, N. J., Cochran, J. N., Sirkis, D. W., Hwang, J.-H., Bonham, L. W., Ramos, E. M., Diaz, A., Van Berlo, V., Dokuru, D., Nana, A. L., Karydas, A., Balestra, M. E., Huang, Y., Russo, S. P., Spina, S., Grinberg, L. T., Seeley, W. W., … Yokoyama, J. S. (2019). Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia. Acta Neuropathologica, 137(1), 71–88. https://doi.org/10.1007/s00401-018-1925–9
   Google Scholar
• Gibb, W. R., Luthert, P. J., & Marsden, C. D. (1989). Corticobasal degeneration. Brain: A Journal of Neurology, 112 (Pt 5), 1171–1192. https://doi.org/doi:10.1093/brain/112.5.1171
   Google Scholar
• Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., Manes, F., Dronkers, N. F., Vandenberghe, R., Rascovsky, K., Patterson, K., Miller, B. L., Knopman, D. S., Hodges, J. R., Mesulam, M. M., & Grossman, M. (2011). Classification of primary progressive aphasia and its variants. Neurology, 76(11), 1006–1014. https://doi.org/10.1212/WNL.0b013e31821103e6
   Google Scholar
• Hauw, J. J., Daniel, S. E., Dickson, D., Horoupian, D. S., Jellinger, K., Lantos, P. L., McKee, A., Tabaton, M., & Litvan, I. (1994). Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology, 44(11), 2015–2019. https://doi.org/10.1212/wnl.44.11.2015
   PubMed Web of Science ®Google Scholar
• Hodgkin, J. (1998). Seven types of pleiotropy. The International Journal of Developmental Biology, 42(3), 501–505. https://pubmed.ncbi.nlm.nih.gov/9654038/
   Web of Science ®Google Scholar
• Höglinger, G. U., Melhem, N. M., Dickson, D. W., Sleiman, P. M. A., Wang, L.-S., Klei, L., Rademakers, R., de Silva, R., Litvan, I., Riley, D. E., van Swieten, J. C., Heutink, P., Wszolek, Z. K., Uitti, R. J., Vandrovcova, J., Hurtig, H. I., Gross, R. G., Maetzler, W., Goldwurm, S., … Schellenberg, G. D. (2011). Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nature Genetics, 43(7), 699–705. https://doi.org/10.1038/ng.859
   Google Scholar
• Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., Arzberger, T., Englund, E., Gelpi, E., Giese, A., Irwin, D. J., Meissner, W. G., Pantelyat, A., Rajput, A., van Swieten, J. C., … Movement Disorder Society-endorsed PSP Study Group. (2017). Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Movement Disorders: Official Journal of the Movement Disorder Society, 32(6), 853–864. https://doi.org/10.1002/mds.26987
   Google Scholar
• Houlden, H., Baker, M., Morris, H. R., MacDonald, N., Pickering-Brown, S., Adamson, J., Lees, A. J., Rossor, M. N., Quinn, N. P., Kertesz, A., Khan, M. N., Hardy, J., Lantos, P. L., St George-Hyslop, P., Munoz, D. G., Mann, D., Lang, A. E., Bergeron, C., Bigio, E. H., … Hutton, M. (2001). Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology, 56(12), 1702–1706. https://doi.org/10.1212/wnl.56.12.1702
   Google Scholar
• Hughes, A. J., Daniel, S. E., Ben-Shlomo, Y., & Lees, A. J. (2002). The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain: A Journal of Neurology, 125(Pt 4), 861–870. https://doi.org/doi:10.1093/brain/awf080
   Google Scholar
• Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R. C., Stevens, M., de Graaff, E., Wauters, E., … Heutink, P. (1998). Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393(6686), 702–705. https://doi.org/10.1038/31508
   Google Scholar
• Irwin, D. J. (2016). Tauopathies as Clinicopathological Entities. Parkinsonism & Related Disorders, 22(01), S29–S33. https://doi.org/doi:10.1016/j.parkreldis.2015.09.020
   Web of Science ®Google Scholar
• Jabbari, E., Woodside, J., Tan, M. M. X., Pavese, N., Bandmann, O., Ghosh, B. C. P., Massey, L. A., Capps, E., Warner, T. T., Lees, A. J., Revesz, T., Holton, J. L., Williams, N. M., Grosset, D. G., & Morris, H. R. (2019). The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy. Movement Disorders, 34(9), 1307–1314. https://doi.org/10.1002/mds.27786
   PubMed Web of Science ®Google Scholar
• Katsuse, O., Iseki, E., Arai, T., Akiyama, H., Togo, T., Uchikado, H., Kato, M., de Silva, R., Lees, A., & Kosaka, K. (2003). 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathologica, 106(3), 251–260. https://doi.org/10.1007/s00401-003-0728-8
   PubMed Web of Science ®Google Scholar
• Komori, T., Arai, N., Oda, M., Nakayama, H., Mori, H., Yagishita, S., Takahashi, T., Amano, N., Murayama, S., Murakami, S., Shibata, N., Kobayashi, M., Sasaki, S., & Iwata, M. (1998). Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathologica, 96(4), 401–408. https://doi.org/10.1007/s004010050911
   PubMed Web of Science ®Google Scholar
• Kouri, N., Ross, O. A., Dombroski, B., Younkin, C. S., Serie, D. J., Soto-Ortolaza, A., Baker, M., Finch, N. C. A., Yoon, H., Kim, J., Fujioka, S., McLean, C. A., Ghetti, B., Spina, S., Cantwell, L. B., Farlow, M. R., Grafman, J., Huey, E. D., Ryung Han, M., … Dickson, D. W. (2015). Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nature Communications, 6. https://doi.org/10.1038/ncomms8247
   Google Scholar
• Kramer, J. H., Jurik, J., Sha, S. J., Rankin, K. P., Rosen, H. J., Johnson, J. K., & Miller, B. L. (2003). Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cognitive and Behavioral Neurology: Official Journal of the Society for Behavioral and Cognitive Neurology, 16(4), 211–218. https://doi.org/10.1097/00146965–200312000–00002
   Google Scholar
• Ling, H., O’Sullivan, S. S., Holton, J. L., Revesz, T., Massey, L. A., Williams, D. R., Paviour, D. C., & Lees, A. J. (2010). Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain: A Journal of Neurology, 133(Pt 7), 2045–2057. https://doi.org/10.1093/brain/awq123
   PubMed Web of Science ®Google Scholar
• Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., Hallett, M., Jankovic, J., Quinn, N. P., Tolosa, E., & Zee, D. S. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology, 47(1), 1–9. https://doi.org/10.1212/wnl.47.1.1
   PubMed Web of Science ®Google Scholar
• Litvan, I., Agid, Y., Goetz, C., Jankovic, J., Wenning, G. K., Brandel, J. P., Lai, E. C., Verny, M., Ray-Chaudhuri, K., McKee, A., Jellinger, K., Pearce, R. K., & Bartko, J. J. (1997). Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study. Neurology, 48(1), 119–125. https://doi.org/10.1212/wnl.48.1.119
   Google Scholar
• Litvan, I., Grimes, D. A., Lang, A. E., Jankovic, J., McKee, A., Verny, M., Jellinger, K., Chaudhuri, K. R., & Pearce, R. K. (1999). Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. Journal of Neurology, 246 Suppl 2, 1–5. https://doi.org/10.1007/bf03161075
   Google Scholar
• Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., Nelson, P. T., Schneider, J. A., Thal, D. R., Trojanowski, J. Q., Vinters, H. V., & Hyman, B. T. (2012). National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: A practical approach. Acta Neuropathologica, 123(1), 1–11. https://doi.org/10.1007/s00401-011-0910-3
   PubMed Web of Science ®Google Scholar
• Murray, R., Neumann, M., Forman, M. S., Farmer, J., Massimo, L., Rice, A., Miller, B. L., Johnson, J. K., Clark, C. M., Hurtig, H. I., Gorno-Tempini, M. L., Lee, V. M.-Y., Trojanowski, J. Q., & Grossman, M. (2007). Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology, 68(16), 1274–1283. https://doi.org/10.1212/01.wnl.0000259519.78480.c3
   Google Scholar
• Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., Hillis, A. E., Josephs, K. A., Boeve, B. F., Kertesz, A., Seeley, W. W., Rankin, K. P., Johnson, J. K., Gorno-Tempini, M.-L., Rosen, H., … Miller, B. L. (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 134(9), 2456–2477. https://doi.org/10.1093/brain/awr179
   Google Scholar
• Rebeiz, J. J., Kolodny, E. H., & Richardson, E. P. (1968). Corticodentatonigral degeneration with neuronal achromasia. Archives of Neurology, 18, 20–33. https://doi.org/doi:10.1001/archneur.1968.00470310034003
   PubMedGoogle Scholar
• Riley, D. E., Lang, A. E., Lewis, A., Resch, L., Ashby, P., Hornykiewicz, O., & Black, S. (1990). Cortical-basal ganglionic degeneration. Neurology, 40(8), 1203–1212. https://doi.org/10.1212/wnl.40.8.1203
   PubMed Web of Science ®Google Scholar
• Sanders, A. R., Göring, H. H. H., Duan, J., Drigalenko, E. I., Moy, W., Freda, J., He, D., Shi, J., & Gejman, P. V. (2013). Transcriptome study of differential expression in schizophrenia. Human Molecular Genetics, 22(24), 5001–5014. https://doi.org/10.1093/hmg/ddt350
   Google Scholar
• Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998). alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies. Proceedings of the National Academy of Sciences of the United States of America, 95(11), 6469–6473. https://doi.org/doi:10.1073/pnas.95.11.6469
   Web of Science ®Google Scholar
• Spina, S., Brown, J. A., Deng, J., Gardner, R. C., Nana, A. L., Hwang, J.-H. L., Gaus, S. E., Huang, E. J., Kramer, J. H., Rosen, H. J., Kornak, J., Neuhaus, J., Miller, B. L., Grinberg, L. T., Boxer, A. L., & Seeley, W. W. (2019). Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies. Brain: A Journal of Neurology, 142(7), 2068–2081. https://doi.org/10.1093/brain/awz122
   Google Scholar
• Steele, J. C., Richardson, J. C., & Olszewski, J. (1964). PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. Archives of Neurology, 10, 333–359. https://doi.org/doi:10.1001/archneur.1964.00460160003001
   PubMed Web of Science ®Google Scholar
• Suzuki, K., Hashimoto, K., Iwata, Y., Nakamura, K., Tsujii, M., Tsuchiya, K. J., Sekine, Y., Suda, S., Sugihara, G., Matsuzaki, H., Sugiyama, T., Kawai, M., Minabe, Y., Takei, N., & Mori, N. (2007). Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism. Biological Psychiatry, 62(3), 267–269. https://doi.org/10.1016/j.biopsych.2006.08.001
   Google Scholar
• Togo, T., & Dickson, D. W. (2002). Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease. Acta Neuropathol (Berl), 104(1), 53–56. https://doi.org/doi:10.1007/s00401-002-0520-1
   Web of Science ®Google Scholar
• Vandrovcova, J., Anaya, F., Kay, V., Lees, A., Hardy, J., & de Silva, R. (2010). Disentangling the role of the tau gene locus in sporadic tauopathies. Current Alzheimer Research, 7(8), 726–734. https://doi.org/doi:10.2174/156720510793611619
   Web of Science ®Google Scholar
• Wassink, T. H., Piven, J., Vieland, V. J., Jenkins, L., Frantz, R., Bartlett, C. W., Goedken, R., Childress, D., Spence, M. A., Smith, M., & Sheffield, V. C. (2005). Evaluation of the chromosome 2q37.3 gene CENTG2 as an autism susceptibility gene. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics, 136B(1), 36–44. https://doi.org/10.1002/ajmg.b.30180
   Google Scholar
• Yokoyama, J. S., Karch, C. M., Fan, C. C., Bonham, L. W., Kouri, N., Ross, O. A., Rademakers, R., Kim, J., Wang, Y., Höglinger, G. U., Muller, U., Ferrari, R., Hardy, J., Momeni, P., Sugrue, L. P., Hess, C. P., Barkovich, A. J., Boxer, A. L., Seeley, W. W., … Desikan, R. S. (2017). Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathologica, 133(5), 825–837. https://doi.org/10.1007/s00401-017-1693–y
   Google Scholar
• Yoshida, M. (2014). Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration. Neuropathol Off J Jpn Soc Neuropathol, 34(6), 555–570. https://doi.org/doi:10.1111/neup.12143
   Web of Science ®Google Scholar